Your browser doesn't support javascript.
loading
A surviving patient after a cumulative dose of 250 g of cyclophosphamide.
Mercan, R; Bitik, B; Ekinci, Ö; Goker, B.
Affiliation
  • Mercan R; a Internal Medicine, Department of Rheumatology , Antakya Hospital , Hatay.
  • Bitik B; b Department of Internal Medicine, Division of Rheumatology , Gazi University Hospital , Ankara , Turkey.
  • Ekinci Ö; c Department of Pathology , Gazi University Hospital , Ankara , Turkey.
  • Goker B; b Department of Internal Medicine, Division of Rheumatology , Gazi University Hospital , Ankara , Turkey.
Scand J Rheumatol ; 44(6): 520-1, 2015.
Article in En | MEDLINE | ID: mdl-26291486
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Scleritis / Cyclophosphamide Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Scand J Rheumatol Year: 2015 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Scleritis / Cyclophosphamide Type of study: Diagnostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Scand J Rheumatol Year: 2015 Document type: Article Country of publication: United kingdom